bra-corpus-v1

The frozen evidence corpus

40 real PubMed abstracts, fetched via NCBI E-utilities and frozen at 2026-09-08T00:00:00Z. Every PMID below resolves at pubmed.ncbi.nlm.nih.gov — nothing here is generated or paraphrased.

The frozen evidence corpus

Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.

Hormone replacement therapy in healthy BRCA1 and 2 mutation carriers after risk-reducing salpingo-oophorectomy: A 5 Ws and 2 Hs practitioner toolkit.

Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant.

DDIAS shields single-stranded DNA in mitosis and promotes vertebrate brain development.

Risk of breast cancer after ovarian cancer in germline BRCA1/2 heterozygotes.

PARP inhibitors and the tumor micro-environment: Bidirectional crosstalk, resistance mechanisms, and therapeutic opportunities.

First-Line Maintenance Therapy Patterns in BRCA Wild-Type, HRD-Negative or Biomarker-Unknown Advanced Epithelial Ovarian Cancer: A Five-Country European Real-World Study by APLUSA.

Extended Germline Profiling of Cancer Predisposition and Homologous Recombination Repair Genes in 275 Russian Patients with Triple-Negative Breast Cancer.

Exploring Traditional Breast Cancer Risk Genes Among Aboriginal and Torres Strait Islander Women.

From comparative oncology to AI-enabled precision medicine: translational biomodels for triple-negative breast cancer.

Multi-ancestry sequencing analysis in 293,141 participants identifies predisposition DNA repair genes associated with HCC risk.

The1H, 15N and13C backbone resonance assignments of an intrinsically disordered region (124-270) of BRCA1 associated RING domain 1 (BARD1).

Association of MDM2 rs2279744 and rs937282 polymorphisms with breast cancer susceptibility and circulating MDM2 and p53 levels in Bangladeshi women: A case-control study.

Random (UV) Mutagenesis, Unbiased Screening and Identification of DNA Repair Mutants by Complementation Cloning.

An overview of the DNA damage response in female reproductive system and breast cancers: A narrative review.

A Heterogeneous Phenotypic Presentation of a PALB2 Mutation Carrier With Multiple Metachronous Primary Malignancies: A Case Report.

The 1H, 15N and 13C backbone resonance assignments of an intrinsically disordered region (467-696) of breast cancer type 1 susceptibility protein (BRCA1).

Endogenous Bornavirus-Like Nucleoprotein 1 Regulates Cellular Processes and DNA Double-Strand Breaks in U-87 MG Glioblastoma Cells.

Molecular profiling of pancreatic acinar cell carcinoma and amphicrine-like carcinoma: high frequency of homologous recombination deficiency and molecular heterogeneity.

Coincidence of L1 retrotransposition and DNA repair deficiency elicits synthetic lethality in S-phase mature neurons.

Cyclin-dependent kinase 4 and 6 inhibitors and the breast cancer immune ecosystem: immune remodeling, resistance, and therapeutic reprogramming.

Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance.

Mutant p53 Gain-of-Function and Immune Suppression: Mathematical Modeling of STING-TBK1-IRF3 Axis Restoration for Enhanced Cancer Therapy.

Inavolisib for PIK3CA-mutated advanced endometrial cancer: a multicentric, phase II, MITO END-4 trial.

Covalent Targeting and Thermostabilization of Oncogenic R280K and R273H Mutants p53 by Small Molecule RVJB59.

The diagnostic value of cyclin d1, EGFR, P53 and Ki-67 in epithelial dysplasi of the gallbladder.

Sclareol Inhibit Cell Growth and Induces Apoptosis via Activation of p53/p21 Signaling Pathways in Human Oral Squamous Cell Carcinoma Cells.

Metabolic Activation-Dependent Anti-Liver Cancer Activity and Organ-Specific Toxicity of Retrorsine From Fanhuncao (Jacobaea cannabifolia and J. litvinovii).

The GH-IGF axis in growth: An overview.

[BRCA1 Gene's Mutations And Hereditary Breast Cancer: Genetic, Biological, And Clinical Aspects].

Halvade somatic: Somatic variant calling with Apache Spark.

FVC as an adaptive and accurate method for filtering variants from popular NGS analysis pipelines.

Multithreaded variant calling in elPrep 5.

Customized de novo mutation detection for any variant calling pipeline: SynthDNM.

Estimating sequencing error rates using families.

Detection of tumor suppressor protein p53 with special emphasis on biosensors: A review.

Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.

The tetramerization domain of the tree shrew p53 protein displays unique thermostability despite sharing high sequence identity with the human p53 protein.

Prognostic significance of the tumor suppressor protein p53 gene in childhood acute lymphoblastic leukemia.

Assessment of TP53 lesions for p53 system functionality and drug resistance in multiple myeloma using an isogenic cell line model.